Sex differences in hemodynamics and outcomes after transcatheter aortic valve replacement
Clinical Research in Cardiology · 2025
DOI: 10.1007/s00392-025-02794-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Henning Guthoff und 33 weiteren Autor:innen. Beteiligte Einrichtung: Clinic III for Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Hemodynamics, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Registries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Medizinische Fakultät, Universität zu Köln, Center For Molecular Medicine Cologne.
Abstract (Originalsprache)
Background
Women remain underrepresented in transcatheter aortic valve replacement (TAVR) trials, despite well-recognized anatomical differences that necessitate tailored procedural strategies. This study assessed sex-specific differences in baseline characteristics, procedural approaches, hemodynamic outcomes, and their impact on 5-year all-cause mortality.
Methods
We analyzed data from 20,094 patients in the IMPPACT TAVR registry. Hemodynamic outcomes, including prosthesis-patient mismatch (PPM), were defined according to Valve Academic Research Consortium-3 criteria. Kaplan–Meier and Cox models assessed 5-year all-cause mortality, and logistic regression identified predictors of PPM.
Results
Women comprised 49.1% of the cohort. They were older (81.4 vs. 80.2 years, p < 0.001), more symptomatic (NYHA ≥ III: 74.4% vs. 67.6%, p < 0.001), and more frequently received self-expanding valves (66.5% vs. 45.7%, p < 0.001). Post-TAVR indexed effective orifice areas were slightly larger in women (1.01 ± 0.28 vs. 0.99 ± 0.27cm 2 /m 2 , p < 0.001). Five-year mortality was lower in women (HR 0.81, 95% CI 0.76–0.86, p < 0.001). Severe PPM occurred less frequently in women (4.0% vs. 4.5%, p < 0.001) and was associated with increased mortality only in men (HR 1.32, 95% CI 1.10–1.59, p = 0.002). Adjustment for comorbidities nullified the association between PPM and mortality in both sexes.
Conclusions
In this international TAVR cohort, women, despite being older, demonstrated better survival than men, with comparable postprocedural hemodynamic outcomes. Severe PPM was associated with increased mortality only in men, likely reflecting underlying comorbidities and low-flow states. After adjustment for confounders, PPM was no longer associated with survival in either sex. These findings underscore the need for strategies accounting for both procedural and patient-specific risks, beyond prosthesis hemodynamics. Graphical Abstract Sex-Specific Differences in TAVR, ( A ) Kaplan-Meier curves with 95% CI for all-cause mortality stratified by sex. ( B ) TTE-derived non-indexed and BSA-indexed pre-TAVR AVA and post-TAVR EOA stratified by sex. ( C ) Distribution of PPM severity stratified by device type and sex. ( D ) Forest plot showing results of the multivariable Cox proportional hazards model for 5-year all-cause mortality including a comparison of severe PPM against non-severe PPM (no and moderate) in men and women. HR with 95% CI are shown. Study center was included as a random effect in the model. Abbreviations: AVA: aortic valve area; BE: balloon-expandable; CI: confidence interval; EOA: effective orifice area; GFR: glomerular filtration rate; HR: hazard ratio; KM: Kaplan-Meier; LVEF: left ventricular ejection fraction; PPM: prosthesis-patient mismatch; PVL: paravalvular leak; SE: self-expanding
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic III for Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
- Center for Cardiovascular Medicine ABCD, Aachen, Bonn, Cologne, Düsseldorf, Germany.
- Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
- Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany.
- Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany.
- Department of Cardiology, Justus-Liebig University of Giessen, Giessen, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Medizinische Fakultät, Universität zu Köln
- Center For Molecular Medicine Cologne
- Universität zu Köln
Zitieren
APA
Guthoff, H., Abdel-Waha, M., Kim, W. K., Wienemann, H., Shamekhi, J., Eckel, C., von der Heide, I., Veulemans, V., Landt, M., Schewel, J., Van Mieghem, N. M., Adrichem, R., Toggweiler, S., Rheude, T., Macherey-Meyer, S., Bleiziffer, S., Al-Kassou, B., Nienaber, S., Wrobel, J., …, & IMPPACT TAVR Investigators (2025). Sex differences in hemodynamics and outcomes after transcatheter aortic valve replacement. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02794-2
Vancouver
Guthoff H, Abdel-Waha M, Kim WK, Wienemann H, Shamekhi J, Eckel C, et al. Sex differences in hemodynamics and outcomes after transcatheter aortic valve replacement. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-025-02794-2
BibTeX
@article{Guthoff2025,
author = {Guthoff, Henning and Abdel-Waha, Mohamed and Kim, Won-Keun and Wienemann, Hendrik and Shamekhi, Jasmin and Eckel, Clemens and von der Heide, Ina and Veulemans, Verena and Landt, Martin and Schewel, Jury and Van Mieghem, Nicolas M and Adrichem, Rik and Toggweiler, Stefan and Rheude, Tobias and Macherey-Meyer, Sascha and Bleiziffer, Sabine and Al-Kassou, Baravan and Nienaber, Stephan and Wrobel, Jan and Richter, Ines and Möllmann, Helge and Renker, Matthias and Charitos, Efstratios and Schofer, Niklas and Zeus, Tobias and Schmidt, Tobias and von Stein, Philipp and Thiele, Holger and Witberg, Guy and Adam, Matti and Baldus, Stephan and Rudolph, Tanja K and Mauri, Victor and IMPPACT TAVR Investigators, IMPPACT TAVR Investigators},
title = {Sex differences in hemodynamics and outcomes after transcatheter aortic valve replacement},
journal = {Clinical Research in Cardiology},
year = {2025},
doi = {10.1007/s00392-025-02794-2}
}
EUVIMED